This released today....
The Supplementary Prospectus has been issued to update investors in relation to inbound enquiries Atomo has received from diagnostic companies based in Europe, the USA and China who have developed blood-based rapid antibody tests for Covid-19 and who are interested in commercialising these for self-testing on Atomo self-test devices.
COVID-19, page-3
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.17M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 703962 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 44601 | 2 |
View Market Depth
| Last trade - 16.12pm 02/05/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |
Day chart unavailable